Racial disparities in cancer care, an eyeopener for developing better global cancer management strategies.

Cancer Rep (Hoboken) · 2023 · PMC10440846 · PMID 36971312

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

For NSCLC‐focused treatment studies, genomic analysis is frequently a requirement for inclusion; as a result, disparities in comprehensive molecular profiling/NGS analysis may be significant in discrepancies in trial enrollment among racial groups.

also in 7,717 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.